Coote D, Davis MR, Cabrera M, Needham M, Laing NG, Nowak KJ. Clinical Utility Gene Card for: Becker muscular dystrophy. Eur J Hum Genet. 2018; 26(7):1065-1071. doi: 10.1038/s41431-017-0064-4.

Advances in inclusion body myositis: genetics, pathogenesis and clinical aspects Needham M, Mastaglia F Expert Opinion on Orphan Drugs, Volume 5, Issue 5, 4 May 2017, Pages 431-443 [Scimago – Quartile, Q2; Rank, 14,070]

A Systematic Review and Meta-Analysis of Prevalence Studies of Sporadic Inclusion Body Myositis Callan, A., Capkun, G., Vasanthaprasad, V., Freitas, R., Needham, M Journal of Neuromuscular Diseases 4(2), pp. 127-137, 2017 [Scimago – Quartile, Q2; Rank, 6,261]

Ghaoui, R., Palmio, J., Brewer, J., Lek, M., Needham, M., Evilä, A., Hackman, P., Jonson, P.H., Penttilä, S., Vihola, A., Huovinen, S., Lindfors, M., Davis, R.L., Waddell, L., Kaur, S., Yiannikas, C., North, K., Clarke, N., Macarthur, D.G., Sue, C.M., Udd, B. 2016, ‘Mutations in HSPB8 causing a new phenotype of distal myopathy and motor neuropathy’, Neurology, 86, 4, pp. 391-398. Detail

Ghaoui, R., Cooper, S.T., Lek, M., Jones, K., Corbett, A., Reddel, S.W., Needham, M., Liang, C., Waddell, L.B., Nicholson, G., O’Grady, G., Kaur, S., Ong, R., Davis, M., Sue, C.M., Laing, N.G., North, K.N., MacArthur, D.G., Clarke, N.F. 2015, ‘Use of whole-exome sequencing for diagnosis of limb-girdle muscular dystrophy: Outcomes and lessons learned’, JAMA Neurology, 72, 12, pp. 1424-1432. Detail

Lloyd, T.E., Mammen, A.L., Amato, A.A., Weiss, M.D., Needham, M., Greenberg, S.A. 2014, ‘Evaluation and construction of diagnostic criteria for inclusion body myositis’, Neurology, 83, 5, pp. 426-433. Detail

Rodríguez Cruz, P.M., Needham, M., Hollingsworth, P.N., Mastaglia, F.L., Hillman, D.R. 2014, ‘Sleep disordered breathing and subclinical impairment of respiratory function are common in sporadic inclusion body myositis’, Neuromuscular Disorders, 24, 12, pp. 1036-1041. Detail

Luo, L, Johnsen, R.D., Griffiths, L, Needham, M., Fabian, V.A., Fletcher, S., Wilton, S.D., Mastaglia, F.L. 2013, ‘Primary over-expression of AbetaPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AbetaPP transgenic mouse’, INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 94, pp. 418-425. Detail

Mastaglia, F.L., Rojana-udomsart, A., James, I., Needham, M., Day, T.J., Kiers, L., Corbett, J.A., Saunders, A.M., Lutz, M.W., Roses, A.D.2013, ‘Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms’, Neuromuscular Disorders, 23, 12, pp. 969-974. Detail

Luo, Y.-B., Mitrpant, C., Johnsen, R., Fabian, V., Needham, M., Fletcher, S., Wilton, S.D., Mastaglia, F.L. 2013, ‘Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis’, International Journal of Clinical and Experimental Pathology, 6, 9, pp. 1723-1733. Detail